Daniel Ansari

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 14

Top Topics

Extracellular Matrix

Top Venues

Cancer control : journal of the Moffitt Cancer Center

Scandinavian journal of gastroenterology

Cell biology and toxicology

This page only lists publications with an associated author ORCID identifier.

Publications

Ragnar Norrsell, Monika Bauden, Roland Andersson, Daniel Ansari
L-type Amino Acid Transporter 1 as a Therapeutic Target in Pancreatic Cancer. Cancer control : journal of the Moffitt Cancer Center 31 (2024)
Ragnar Norrsell, Monika Bauden, Roland Andersson, Daniel Ansari
L-type Amino Acid Transporter 1 as a Therapeutic Target in Pancreatic Cancer. Cancer control : journal of the Moffitt Cancer Center 31 (2024)
Ragnar Norrsell, Monika Bauden, Roland Andersson, Daniel Ansari
L-type Amino Acid Transporter 1 as a Therapeutic Target in Pancreatic Cancer. Cancer control : journal of the Moffitt Cancer Center 31 (2024)
Ragnar Norrsell, Monika Bauden, Roland Andersson, Daniel Ansari
L-type Amino Acid Transporter 1 as a Therapeutic Target in Pancreatic Cancer. Cancer control : journal of the Moffitt Cancer Center 31 (2024)
Axel Bengtsson, Roland Andersson, Jonas Rahm, Karthik Ganganna, Bodil Andersson, Daniel Ansari
Organoid technology for personalized pancreatic cancer therapy. Cellular oncology (Dordrecht) 44 (2) (2021)
Linus Aronsson, Roland Andersson, Daniel Ansari
Artificial neural networks versus LASSO regression for the prediction of long-term survival after surgery for invasive IPMN of the pancreas. PloS one 16 (3) (2021)
Zachary C K Hawes, Rebecca Merkley, Christine L Stager, Daniel Ansari
Integrating numerical cognition research and mathematics education to strengthen the teaching and learning of early number. The British journal of educational psychology 91 (4) (2021)
Qimin Zhou, Monika Bauden, Roland Andersson, Dingyuan Hu, György Marko-Varga, Jianfeng Xu, Agata Sasor, Hua Dai, Krzysztof Pawłowski, Katarzyna Said Hilmersson, Xi Chen, Daniel Ansari
YAP1 is an independent prognostic marker in pancreatic cancer and associated with extracellular matrix remodeling. Journal of translational medicine 18 (1) (2020)
Dingyuan Hu, Daniel Ansari, Qimin Zhou, Agata Sasor, Katarzyna Said Hilmersson, Roland Andersson
Galectin 4 is a biomarker for early recurrence and death after surgical resection for pancreatic ductal adenocarcinoma. Scandinavian journal of gastroenterology 54 (1) (2019)
Dingyuan Hu, Daniel Ansari, Qimin Zhou, Agata Sasor, Katarzyna Said Hilmersson, Roland Andersson
Low P4HA2 and high PRTN3 expression predicts poor survival in patients with pancreatic cancer. Scandinavian journal of gastroenterology 54 (2) (2019)
Daniel Ansari, William Torén, Qimin Zhou, Dingyuan Hu, Roland Andersson
Proteomic and genomic profiling of pancreatic cancer. Cell biology and toxicology 35 (4) (2019)
Daniel Ansari, Carl Althini, Henrik Ohlsson, Roland Andersson
Early-onset pancreatic cancer: a population-based study using the SEER registry. Langenbeck's archives of surgery 404 (5) (2019)
Anton Deicher, Roland Andersson, Bobby Tingstedt, Gert Lindell, Monika Bauden, Daniel Ansari
Targeting dendritic cells in pancreatic ductal adenocarcinoma. Cancer cell international 18 (2018)
Monika Bauden, Theresa Kristl, Agata Sasor, Bodil Andersson, György Marko-Varga, Roland Andersson, Daniel Ansari
Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma. BMC cancer 17 (1) (2017)